StandardX 🇬🇧
Compact particle-accelerator platform producing medical, industrial and energy isotopes near the point of use. London.
About StandardX
StandardX has developed a scalable isotope production platform utilizing a compact particle accelerator to generate a diverse range of isotopes essential for applications in medicine, industry, and energy. This proprietary technology aims to produce these critical materials closer to their point of use, enhancing efficiency in their distribution and application.
StandardX is a UK-based company founded in 2025, now around 14 people. FundFinder classes it as Health & Bio.
Founded by Ross Allen (Co-Founder & CTO; previously National Physical Laboratory (NPL), Oxford Sigma; University of Birmingham), Richard Pearson (Co-Founder & CEO; repeat founder; previously Clean Air Task Force, Cobham; The Open University).
Its investors also appear on FundFinder's most-active lists for Seed · DeepTech (80 funds), Seed · Climate & Sustainability (80 funds), Seed · Life Sciences (32 funds).
Company facts from Harmonic and public filings; team backgrounds from public profiles. Refreshed weekly.
Seed · Sep 2026
- UK Innovation & Science Seed Fund (UKI2S) — Evergreen, government-backed pre-seed+ fund managed by Future Planet Capital. · cheques up to £1.5M